Overexpression of LARGE suppresses muscle regeneration via down-regulation of insulin-like growth factor 1 and aggravates muscular dystrophy in mice (Q39005429)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 April 2014

Language	Label	Description	Also known as
English	Overexpression of LARGE suppresses muscle regeneration via down-regulation of insulin-like growth factor 1 and aggravates muscular dystrophy in mice	scientific article published on 9 April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Overexpression of LARGE suppresses muscle regeneration via down-regulation of insulin-like growth factor 1 and aggravates muscular dystrophy in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

based on heuristic

inferred from title

muscular dystrophy

1 reference

based on heuristic

inferred from title

author name string

Fumiaki Saito

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Motoi Kanagawa

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Miki Ikeda

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Hiroki Hagiwara

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Toshihiro Masaki

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Hidehiko Ohkuma

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Yuki Katanosaka

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Teruo Shimizu

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Masahiro Sonoo

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Tatsushi Toda

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Kiichiro Matsumura

11

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

9 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Human Molecular Genetics

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

4543-4558

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

A stoichiometric complex of neurexins and dystroglycan in brain

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Identification and characterization of the dystrophin anchoring site on beta-dystroglycan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Molecular recognition by LARGE is essential for expression of functional dystroglycan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Processing and secretion of the N-terminal domain of alpha-dystroglycan in cell culture media

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

A dystroglycan mutation associated with limb-girdle muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

The congenital muscular dystrophies in 2004: a century of exciting progress

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Identification of a novel mutant transcript of laminin α2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Elevated satellite cell number in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Role of IGF-I in skeletal muscle mass maintenance

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Transgenic overexpression of LARGE induces α-dystroglycan hyperglycosylation in skeletal and cardiac muscle

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Muscle-specific expression of LARGE restores neuromuscular transmission deficits in dystrophic LARGE(myd) mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Laminin-induced activation of Rac1 and JNKp46 is initiated by Src family kinases and mimics the effects of skeletal muscle contraction

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDU168

21 January 2018

Identifiers

10.1093/HMG/DDU168

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39005429&oldid=1801952883"